Market Exclusive

Analyst Activity – Cantor Fitzgerald Reiterates Hold on AMAG Pharmaceuticals (NASDAQ:AMAG)

Analyst Ratings For AMAG Pharmaceuticals (NASDAQ:AMAG)

Today, Cantor Fitzgerald reiterated its Hold rating on AMAG Pharmaceuticals (NASDAQ:AMAG).

There are 1 sell rating, 9 hold ratings, 2 buy ratings on the stock.

The current consensus rating on AMAG Pharmaceuticals (NASDAQ:AMAG) is Hold (Score: 2.08) with a consensus target price of $28.70 per share, a potential 44.58% upside.

Some recent analyst ratings include


Recent Trading Activity for AMAG Pharmaceuticals (NASDAQ:AMAG)
Shares of AMAG Pharmaceuticals closed the previous trading session at 19.85 up +0.55 2.85% with 626,228 shares trading hands.

Exit mobile version